<DOC>
<DOCNO>EP-0628562</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Cephalospornis having in position 7 as substituted axymino radical, intermediates, processes for their preparation and their use as medicaments.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31545	A61K31545	A61K31546	A61K31546	A61P3100	A61P3104	C07D50100	C07D50100	C07D50124	C07D50148	C07D50156	C07D51900	C07D51906	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61P31	A61P31	C07D501	C07D501	C07D501	C07D501	C07D501	C07D519	C07D519	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The subject of the invention is the products of general formula (I):   
<
IMAGE
>
 syn isomer, in the (R) or (S) form or in the form of an (R,S) mixture, in the form of an internal salt or of their salts with inorganic or organic acids, in which formula:  R1 represents a group of formula (K): 
<
IMAGE
>
 in which R'1 is alkyl (1 to 4 carbons), cyano, carboxy or alkoxycarbonyl (1 to 4 carbons alkyl) or R1 represents a group of formula (L): 
<
IMAGE
>
 A and A' represent a hydrogen or an equivalent of alkali metal or alkaline-earth metal, of magnesium, of ammonium or of an organic amino base or else one alone or each of the CO2A or CO2A' groups represent CO2
<
-
>
 and R2 a quaternary ammonium. These products have advantageous pharmacological properties which justify their use as medicaments.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
ROUSSEL UCLAF
</APPLICANT-NAME>
<APPLICANT-NAME>
ROUSSEL UCLAF
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ASZODI JOZSEF
</INVENTOR-NAME>
<INVENTOR-NAME>
DINI CHRISTOPHE
</INVENTOR-NAME>
<INVENTOR-NAME>
FAUVEAU PATRICK
</INVENTOR-NAME>
<INVENTOR-NAME>
ASZODI, JOZSEF
</INVENTOR-NAME>
<INVENTOR-NAME>
DINI, CHRISTOPHE
</INVENTOR-NAME>
<INVENTOR-NAME>
FAUVEAU, PATRICK
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
